People Pay Up to $1,000 for NAD+ IV Drips Trying to Stop Aging, as Interest in Niche Wellness Climbs
The price tag stops you first. A single NAD+ infusion can run $500 to $1,000, and Hailey Bieber told viewers of a 2022 episode of The Kardashians she was “going to NAD for the rest of my life”. Now a peer-reviewed systematic review published in early 2026 raises an uncomfortable question for anyone considering the drip. Among the human studies that qualified, none tested IV or intramuscular NAD+ itself for anti-aging or wellness outcomes.
Here’s what doctors and researchers say is actually in the bag, and whether the evidence supports the marketing.
How NAD+ IV Therapy Works
NAD+ is a coenzyme found in every cell. It helps convert food into cellular energy and supports DNA repair. As a standalone oral supplement, it’s poorly absorbed, which is the reason clinics give for delivering it intravenously. During a session, the molecule is mixed with saline and dripped into a vein over one to four hours.
Pricing varies widely, and these treatments are among the priciest items on a typical biohacking clinic menu. Restore Hyper Wellness offers a promotional entry-point bundle at $79, while Next Health charges $500 to $1,000 per session. Standard IV drips at the same clinics run $99 to $199, and add-ons like cryotherapy start around $50.
What the Latest NAD+ Research Found
The 2026 PRISMA-guided systematic review by Cory Gallagher and Owoturo Oluwaseun Emmanuel, published in Ageing Research Reviews, screened studies from 2010 through 2025. The authors found 113 eligible studies, 33 of them in humans.
None of the qualifying human trials tested IV or intramuscular NAD+ itself for anti-aging outcomes. One nonrandomized IV study made the cut, but it tested NMN, a precursor molecule, not NAD+ itself, and only contributed safety data.
Oral NAD+ precursors NR and NMN had a stronger human evidence base in the same review, though functional outcomes were still mixed. The lead author also disclosed a conflict of interest, an ownership stake in a management company serving an aesthetics clinic that doesn’t offer NAD+ infusions.
One important caveat. A lack of qualifying trials isn’t the same as proof of harm. The review found gaps in the evidence, not evidence the treatment is dangerous.
What Doctors Say About IV NAD+
Dr. Amanda Kahn, a board-certified internist and longevity medicine specialist, told TODAY, “I am not a proponent of IV therapy because I think you can get too much at once.” She also flagged added infection risk depending on who administers the drip, particularly at less-regulated med spas.
The FDA had excluded NMN from the dietary supplement category back in 2022 over its prior investigation as a drug, but reversed that position in September 2025, confirming NMN can legally be sold as a supplement again. It still has to clear separate premarket notification requirements, so the regulatory picture isn’t fully settled.
Why Celebrities and Clinics Keep Pushing NAD+
Cultural momentum is doing much of the work. Reporting in the South China Morning Post traces the trend through Hailey and Justin Bieber’s endorsements and the broader biohacking scene. Clinics lean on the absorption argument, that the IV route bypasses the gut, to justify both the format and the price.
For shoppers comparing options, the cheaper menu items at the same studios include standard IV drips and Restore’s $79 NAD+ bundle. Oral NR and NMN supplements, while not perfect, have the closest thing to a human evidence base, according to the 2026 review.
What to Ask Before You Book An NAD+ Treatment
If you’re still considering an infusion, the questions doctors recommend are practical ones. Who’s administering the IV, and what are their credentials? What’s the dose and the protocol? Are there published human trials for the specific outcome you’re chasing? On that last point, the 2026 review is blunt. For anti-aging and general wellness, the human trials testing IV NAD+ itself don’t yet exist.
This article was created by content specialists using various tools, including AI.